Dr Samuel Whittle
School of Medicine
College of Health
| Year | Citation |
|---|---|
| 2026 | Russo, P. A. J., Makhzoum, J. -P., Cottin, V., Conticini, E., Emmi, G., & Whittle, S. L. (2026). Janus Kinase Inhibitors in Eosinophilic Granulomatosis With Polyangiitis: An International Case Series.. The Journal of rheumatology, jrheum.2025-jrheum.1128. |
| 2026 | Furtado, R., Marmura, H., Haas, R., Ramiro, S., Verhagen, A., Whittle, S., . . . Buchbinder, R. (2026). Suitability of the Numerical Pain Rating Scale for measuring pain in clinical trials evaluating interventions for people with shoulder disorders according to the OMERACT filter 2.2. Seminars in Arthritis and Rheumatism, 78, 11 pages. |
| 2026 | Kamso, M. M., Whittle, S. L., Pardo, J. P., Buchbinder, R., Wells, G., Deardon, R., . . . Hazlewood, G. S. (2026). Paper 1: a semi-automated approach facilitated the assessment of the certainty of evidence in a network meta-analysis: part 1 – Direct comparisons. Journal of Clinical Epidemiology, 191, 10 pages. Scopus1 |
| 2026 | Kamso, M. M., Whittle, S. L., Pardo, J. P., Buchbinder, R., Wells, G., Deardon, R., . . . Hazlewood, G. S. (2026). Paper 2: a semi-automated approach facilitated the assessment of the certainty of evidence for in a network meta-analysis: part 2 – indirect and mixed comparisons. Journal of Clinical Epidemiology, 191, 10 pages. |
| 2025 | Saadat, P., Bansback, N., Falahee, M., Hiligsmann, M., Tugwell, P., Buchbinder, R., . . . Hazlewood, G. (2025). Patient preferences for drug therapy in inflammatory arthritis: protocol for a living systematic review and evidence map to inform clinical practice guidelines. BMJ Open, 15(1), e088267-1-e088267-7. Scopus1 WoS1 Europe PMC1 |
| 2025 | Synnot, A., Chakraborty, S., Xue, J., Cheng, H. Z., Berkovic, D., Turner, T., . . . Glennon, V. (2025). Exploring the use and usefulness of living guidelines for consumers: international online survey of patients' and carers' views. Journal of Clinical Epidemiology, 180, 111671. Scopus7 Europe PMC7 |
| 2025 | Whittle, S. L., Johnston, R. V., McDonald, S., Worthley, D., Campbell, T. M., Cyril, S., . . . Buchbinder, R. (2025). Stem cell injections for osteoarthritis of the knee. The Cochrane Database of Systematic Reviews, 4(4), CD013342-i-CD013342-362. Scopus9 WoS11 Europe PMC11 |
| 2025 | Chin, A., Terrett, A., Kwon, M., Whittle, S., & Hill, C. (2025). Recommendations for the Use of Disease-Modifying Antirheumatic Drugs in Pregnancy and Reproductive Health for Patients With Rheumatic Disease: A Scoping Review. Arthritis Care and Research, 77(10), 1273-1281. |
| 2025 | Bryant, M. J., Lester, S., Russell, O., Whittle, S., Limaye, V., Proudman, S., . . . Hill, C. L. (2025). Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients. Rheumatology International, 45(6), 10 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | St Pierre, K., Cashmore, B., Cumpston, M. S., Hill, K., McDonald, S., Pattuwage, L., . . . Tunnicliffe, D. J. (2025). Methods for living guidelines: Paper 6: Insights from ALEC’s use of existing systematic reviews in living guideline development. Journal of Clinical Epidemiology, 187, 111812-1-111812-13. Scopus2 WoS1 |
| 2025 | Sukkar, M. B., Ainley, R., Barrett, C., Bond, S., Bradbury, L. A., Briggs, A. M., . . . Hill, C. L. (2025). Development of the Australian Rheumatology Association Clinical Care Standard for the diagnosis and management of rheumatoid arthritis in adults. Journal of Rheumatology, 52(9), 883-892. Europe PMC1 |
| 2025 | Terrett, A. M., Damodaran, A., Burnet, S., Singh-Grewal, D., Buchbinder, R., Glover, J., . . . Hill, C. L. (2025). The rheumatology workforce in Australia: current and projected shortfalls. Internal Medicine Journal, 55(9), 1500-1507. |
| 2025 | White, H., Synnot, A., Glennon, V., Hill, K., Whittle, S., Seid, A., & Turner, T. (2025). Living recommendations do not “flip-flop”: examining the probability of directional changes to recommendations in living guidelines. Journal of Clinical Epidemiology, 185, 8 pages. Scopus3 WoS4 Europe PMC1 |
| 2025 | Terrett, A., Chin, A., Kwon, M., Whittle, S., & Hill, C. (2025). Perioperative management with DMARDs in rheumatic diseases: a scoping review of clinical guidelines. BMC Rheumatology, 9(1), 10 pages. Scopus3 WoS3 Europe PMC2 |
| 2025 | Pisaniello, H. L., Whittle, S. L., Johnston, R. V., Glennon, V., Grobler, L., Cyril, S., . . . Buchbinder, R. (2025). Dose reduction and discontinuation of conventional synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with rheumatoid arthritis or psoriatic arthritis in remission or low disease activity. Cochrane Database of Systematic Reviews, 9(9), CD015900. Scopus1 |
| 2025 | Yiu, Z. Z. N., McFarlane, E., & Whittle, S. L. (2025). ‘Live long and prosper’: living guidelines for immune-mediated inflammatory diseases. Rheumatology, 64(1), 6-8. |
| 2024 | Yiu, Z. Z. N., McFarlane, E., & Whittle, S. L. (2024). ‘Live long and prosper’: living guidelines for immune-mediated inflammatory diseases. British Journal of Dermatology, 191(5), 647-649. |
| 2024 | Ramsay, H., Johnston, R. V., Cyril, S., Glennon, V., Grobler, L., Burgess, D. M., . . . Buchbinder, R. (2024). Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activity. Cochrane Database of Systematic Reviews, 2024(12), CD015880. |
| 2024 | Tan, J., Renton, W. D., Whittle, S. L., Takken, T., Johnston, R. V., Tiller, G., . . . Buchbinder, R. (2024). Methotrexate for juvenile idiopathic arthritis. Cochrane Database of Systematic Reviews, 2024(2), CD003129-1-CD003129-67. Scopus8 WoS10 Europe PMC5 |
| 2024 | Mittinty, M. M., Mittinty, M. N., Buchbinder, R., Lassere, M., Chand, V., Whittle, S., . . . Hill, C. (2024). Interpersonal Process of Dyadic Coping in Rheumatoid Arthritis: A Perspective From the Australian Rheumatology Association Database. Journal of Rheumatology, 51(9), 862-869. Scopus4 WoS3 Europe PMC1 |
| 2024 | Pisaniello, H. L., Lester, S. E., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. L. (2024). The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). Annals of the Rheumatic Diseases, 83(10), 1400-1402. Scopus1 WoS1 |
| 2023 | Whittle, S. L., Glennon, V., & Buchbinder, R. (2023). Prioritization of clinical questions for the Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis. International Journal of Rheumatic Diseases, 26(12), 2410-2418. Scopus5 WoS5 Europe PMC9 |
| 2023 | Kamso, M. M., Pardo, J. P., Whittle, S. L., Buchbinder, R., Wells, G., Glennon, V., . . . Hazlewood, G. S. (2023). Crowd-sourcing and automation facilitated the identification and classification of randomized controlled trials in a living review. Journal of Clinical Epidemiology, 164, 1-8. Scopus6 WoS6 Europe PMC5 |
| 2023 | Ng, J. Q., Jafarov, T. H., Little, C. B., Wang, T., Ali, A. M., Ma, Y., . . . Mukherjee, S. (2023). Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis. Nature Communications, 14(1), 6909-1-6909-14. Scopus32 WoS32 Europe PMC29 |
| 2023 | Wang, H., Dewidar, O., Whittle, S. L., Ghogomu, E., Hazlewood, G., Leder, K., . . . Welch, V. (2023). Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases. Arthritis Care and Research, 75(5), 967-974. |
| 2023 | Cheyne, S., Fraile Navarro, D., Hill, K., McDonald, S., Tunnicliffe, D., White, H., . . . Turner, T. (2023). Methods for living guidelines: early guidance based on practical experience. Paper 1: Introduction. Journal of Clinical Epidemiology, 155, 84-96. Scopus49 WoS48 Europe PMC37 |
| 2023 | Cheyne, S., Fraile Navarro, D., Buttery, A. K., Chakraborty, S., Crane, O., Hill, K., . . . Turner, T. (2023). Methods for living guidelines: early guidance based on practical experience. Paper 3: selecting and prioritizing questions for living guidelines. Journal of Clinical Epidemiology, 155, 73-83. Scopus23 WoS20 Europe PMC15 |
| 2023 | Synnot, A., Hill, K., Davey, J., English, K., Whittle, S. L., Buchbinder, R., . . . Turner, T. (2023). Methods for living guidelines: Early Guidance based on practical experience. Paper 2: Consumer engagement in living guidelines. Journal of Clinical Epidemiology, 155, 97-107. Scopus15 WoS15 Europe PMC14 |
| 2023 | Buchbinder, R., Glennon, V., Johnston, R. V., Brennan, S. E., Fong, C., Edward May, S., . . . Whittle, S. L. (2023). Australian recommendations on perioperative use of disease-modifying anti-rheumatic drugs in people with inflammatory arthritis undergoing elective surgery. Internal Medicine Journal, 53(7), 1248-1255. Scopus5 WoS3 Europe PMC3 |
| 2023 | Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. L. (2023). Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). RMD Open, 9(3), e002962. Scopus7 WoS7 Europe PMC4 |
| 2023 | Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S. L., Rowett, D., . . . Hill, C. L. (2023). Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis. ACR Open Rheumatology, 5(2), 1-9. Scopus7 WoS6 Europe PMC5 |
| 2023 | Taylor, W. J., Willink, R., O'Connor, D. A., Patel, V., Bourne, A., Harris, I. A., . . . Buchbinder, R. (2023). Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT).. PloS one, 18(3), e0281308. Scopus3 WoS2 Europe PMC3 |
| 2023 | Barrett, C., & Whittle, S. (2023). Philip Cameron Robinson, 1979-2023. Internal Medicine Journal, 53(3), 309-310. |
| 2023 | Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., & Keen, H. I. (2023). Response to Correspondence on Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis'' by Reuter et al. Annals of the Rheumatic Diseases, 82(4), E92. |
| 2022 | Renton, W. D., Tiller, G., Munro, J., Tan, J., Johnston, R. V., Avery, J. C., . . . Buchbinder, R. (2022). Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis. Cochrane Database of Systematic Reviews, 2022(1), 1-17. Scopus2 |
| 2022 | Feterman Jimenez, D., Duron, G., Hendin, J., Mantovani Cardoso, E., Valenzuela-Almada, M. O., Vallejo, S., . . . Putman, M. S. (2022). Industry involvement in rheumatology consensus-based recommendations: a systematic review. Lancet Rheumatology, 4(2), e145-e152. |
| 2022 | Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S. L., Hill, C. L., Rowett, D., . . . O'Connor, D. A. (2022). Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Seminars in Arthritis and Rheumatism, 55(151988), 151988-1-151988-13. Scopus5 WoS7 Europe PMC5 |
| 2022 | Lee, C., Thomas, M., Ejaredar., Kassam, A., Whittle, S. L., Buchbinder, R., . . . Hazlewood, G. S. (2022). Crowdsourcing trainees in a living systematic review provided valuable experiential learning opportunities: A mixed-methods study. Journal of Clinical Epidemiology, 147, 142-150. Scopus7 WoS5 Europe PMC5 |
| 2022 | Khoo, T., Hill, C. L., Hoon, E., & Whittle, S. (2022). Patient Perspectives of Disease Activity, Medications and Substance Use in People with Fibromyalgia. Open Access Rheumatology: Research and Reviews, 14, 87-95. Scopus3 WoS3 Europe PMC1 |
| 2022 | Whittle, S. L., Glennon, V., Johnston, R. V., Avery, J. C., Bell, J. S., Brennan, S. E., . . . Buchbinder, R. (2022). Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis. Internal Medicine Journal, 52(10), 1799-1805. Scopus9 WoS7 Europe PMC8 |
| 2022 | Ponkilainen, V., Karjalainen, T. V., Kuitunen, I., Uimonen, M., Johnston, R. V., Saarinen, A., . . . Buchbinder, R. (2022). Perioperative use of disease modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritis. Cochrane Database of Systematic Reviews, 2022(5). Scopus2 |
| 2022 | Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2022). Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Rheumatology Advances in Practice, 6(3), rkac099-1-rkac099-7. Scopus7 WoS8 Europe PMC6 |
| 2022 | Tsakas, J. J., Liew, D. F. L., Adams, C. L., Hill, C. L., Proudman, S., Whittle, S., . . . Robinson, P. C. (2022). Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees. BMC Rheumatology, 6(1), 59-1-59-8. Scopus2 WoS3 Europe PMC1 |
| 2022 | Pisaniello, H. L., Whittle, S. L., Lester, S., Menz, F., Metcalf, R., McWilliams, L., . . . Proudman, S. (2022). Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis. BMC Rheumatology, 6(1), 11 pages. Scopus17 WoS16 Europe PMC14 |
| 2022 | Tiller, G., Renton, W. D., Tan, J., Whittle, S., Avery, J., Munro, J., & Buchbinder, R. (2022). Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis.. Pediatric rheumatology online journal, 20(1), 52. Scopus2 WoS2 Europe PMC3 |
| 2022 | Khoo, T., Chin, A., & Whittle, S. (2022). Fibromyalgia: Small steps on a long journey. Medicine Today, 23(1-2), 43-48. |
| 2021 | Adams, L., Lester, S., Hoon, E., van der Haak, H., Proudman, C., Hall, C., . . . Hill, C. L. (2021). Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia.. Internal medicine journal, 51(7), 1028-1037. Scopus41 WoS41 Europe PMC38 |
| 2021 | Whittle, S. L., Hazlewood, G. S., Robinson, P., Johnston, R. V., Leder, K., Glennon, V., . . . Buchbinder, R. (2021). COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies. Cochrane Database of Systematic Reviews, 2021(6), 16 pages. Scopus1 |
| 2021 | Glennon, V., Whittle, S. L., Hill, C. L., Johnston, R. V., Avery, J. C., Grobler, L., . . . Buchbinder, R. (2021). Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs). Cochrane Database of Systematic Reviews, 2021(11), 16 pages. Scopus5 |
| 2021 | Avery, J. C., Whittle, S. L., Johnston, R. V., Grobler, L., McKenzie, B. J., Cyril, S., . . . Buchbinder, R. (2021). Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity. Cochrane Database of Systematic Reviews, 2021(11), 16 pages. |
| 2021 | McKenzie, B. J., Whittle, S. L., Johnston, R. V., Hill, C. L., Pardo Pardo, J., Glennon, V., . . . Buchbinder, R. (2021). Long-term glucocorticoids for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2021(12), 17 pages. Scopus3 WoS1 |
| 2021 | Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2021). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. ACR Open Rheumatology, 3(4), 231-238. Scopus13 WoS15 Europe PMC11 |
| 2021 | Ferreira, G. E., Zadro, J. R., O'Keeffe, M., Buchbinder, R., Maher, C., Latimer, J., . . . Clavisi, O. (2021). Challenges faced by musculoskeletal health research in Australia and New Zealand due to the COVID-19 pandemic. Internal Medicine Journal, 51(4), 622. Scopus1 Europe PMC1 |
| 2021 | Davis, C. R., Ruediger, C. D., Dyer, K. A., Lester, S., Graf, S. W., Kroon, F. P. B., . . . Hill, C. L. (2021). Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthritis and Cartilage, 29(2), 208-214. Scopus35 WoS30 Europe PMC25 |
| 2021 | Khadra, Y., Walker, J. G., Hakendorf, P., Proudman, S., Rischmueller, M., Hill, C. L., . . . Roberts-Thomson, P. J. (2021). Scleroderma renal crisis: observations from the South Australian Scleroderma Register. Internal Medicine Journal, 51(2), 235-242. Scopus4 WoS3 Europe PMC3 |
| 2020 | Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., Sa'adon, R., & Keen, H. (2020). Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 79(11), 1432-1437. Scopus14 WoS13 Europe PMC13 |
| 2020 | Røe, Y., Buchbinder, R., Grotle, M., Whittle, S., Ramiro, S., Huang, H., . . . Østensjø, S. (2020). What do the OMERACT shoulder core set candidate instruments measure? An analysis using the refined international classification of functioning, disability, and health linking rules. Journal of Rheumatology, 47(10), 1557-1564. Scopus2 WoS3 Europe PMC2 |
| 2020 | Hazlewood, G. S., Whittle, S. L., Kamso, M. M., Akl, E. A., Wells, G. A., Tugwell, P., . . . Buchbinder, R. (2020). Disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews, 2020(3). Scopus22 |
| 2020 | Putman, M. S., Sufka, P., Whittle, S., & Robinson, P. C. (2020). European consensus statements for interstitial lung disease in systemic sclerosis. Lancet Rheumatology, 2(6), e317-e318. Europe PMC1 |
| 2020 | Leonardo, N., Lester, S., Graham, M., Barett, C., Whittle, S., Rowett, D., . . . Hill, C. L. (2020). Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. International Journal of Rheumatic Diseases, 23(6), 805-812. Scopus22 WoS21 Europe PMC18 |
| 2020 | Szeto, C. -C., Sugano, K., Wang, J. -G., Fujimoto, K., Whittle, S., Modi, G. K., . . . Chan, F. K. L. (2020). Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.. Gut, 639(4), 617-629. Scopus117 WoS98 Europe PMC67 |
| 2020 | Buchbinder, R., Bourne, A., Latimer, J., Harris, I., Whittle, S., Richards, B., . . . ANZMUSC Clinical Trial Network. (2020). Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. Internal medicine journal, 50(1), 17-23. Scopus9 WoS8 Europe PMC11 |
| 2020 | Leonardo, N., Lester, S., Whittle, S., & Rischmueller, M. (2020). Review of gout clinic in a tertiary hospital setting.. Intern Med J, 50(1), 117-120. Scopus5 WoS4 Europe PMC4 |
| 2020 | Lowe, J. R., Briggs, A. M., Whittle, S., & Stephenson, M. D. (2020). A systematic review of the effects of probiotic administration in inflammatory arthritis. Complementary Therapies in Clinical Practice, 40, 101207-1-101207-13. Scopus25 WoS20 Europe PMC15 |
| 2020 | Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., & Keen, H. (2020). Sentiment analysis of social media posts on pharmacotherapy: A scoping review. Pharmacology Research and Perspectives, 8(5), 9 pages. Scopus17 WoS13 Europe PMC13 |
| 2020 | Buchbinder, R., Ramiro, S., Huang, H., Gagnier, J. J., Jia, Y., & Whittle, S. L. (2020). Measures of Adult Shoulder Function. Arthritis Care and Research, 72(S10), 250-293. Scopus18 WoS20 Europe PMC17 |
| 2019 | Wilsdon, T. D., Whittle, S. L., Thynne, T. R., & Mangoni, A. A. (2019). Methotrexate for psoriatic arthritis. Cochrane Database of Systematic Reviews, 2019(1), 111 pages. Scopus17 WoS50 Europe PMC30 |
| 2019 | Ramiro, S., Page, M. J., Whittle, S. L., Huang, H., Verhagen, A. P., Beaton, D. E., . . . Buchbinder, R. (2019). The OMERACT core domain set for clinical trials of shoulder disorders. The Journal of Rheumatology, 46(8), 969-975. Scopus38 WoS38 Europe PMC36 |
| 2019 | Tam, L. S., Wei, J. C. C., Aggarwal, A., Baek, H. J., Cheung, P. P., Chiowchanwisawakit, P., . . . Lau, C. S. (2019). 2018 APLAR axial spondyloarthritis treatment recommendations. International Journal of Rheumatic Diseases, 22(3), 340-356. Scopus64 WoS55 Europe PMC44 |
| 2019 | Page, M. J., O'Connor, D. A., Malek, M., Haas, R., Beaton, D., Huang, H., . . . OMERACT Shoulder Core Set Working Group. (2019). Patients' experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set. Rheumatology, 58(8), 1410-1421. Scopus45 WoS48 Europe PMC45 |
| 2019 | Ying Chan, F. L., Lester, S., Whittle, S. L., & Hill, C. L. (2019). The utility of ESR, CRP and platelets in the diagnosis of GCA. BMC Rheumatology, 3(1), 7 pages. Scopus51 WoS43 Europe PMC38 |
| 2019 | Whittle, S. L., Johnston, R. V., McDonald, S., Worthley, D., Campbell, T. M., & Buchbinder, R. (2019). Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2019(5). Scopus13 |
| 2019 | Whittle, S. L., Johnston, R. V., McDonald, S., Paterson, K. L., & Buchbinder, R. (2019). Autologous blood product injections including platelet-rich plasma for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2019(5). Scopus6 |
| 2019 | Cai, K., Whittle, S. L., Richards, B. L., Ramiro, S., Falzon, L., & Buchbinder, R. (2019). Marine oil supplements for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2019(12). Scopus1 |
| 2018 | Wilsdon, T., Thynne, T., Mangoni, A., & Whittle, S. (2018). METHOTREXATE FOR PSORIATIC ARTHRITIS. INTERNAL MEDICINE JOURNAL, 48, 14. |
| 2018 | Bourne, A. M., Johnston, R. V., Cyril, S., Briggs, A. M., Clavisi, O., Duque, G., . . . Buchbinder, R. (2018). Scoping review of priority setting of research topics for musculoskeletal conditions. BMJ Open, 8(12), e023962-1-e023962-9. Scopus37 WoS37 Europe PMC37 |
| 2018 | Pisaniello, H., Lester, S., Gonzalez-Chica, D., Stocks, N., Longo, M., Sharplin, G., . . . Hill, C. (2018). Gout prevalence and predictors of urate-lowering therapy use: Results from a population-based study. Arthritis Research and Therapy, 20(1), 10 pages. Scopus45 WoS41 Europe PMC25 |
| 2018 | Chua, A. C. L., Venkataraman, K., & Whittle, S. L. (2018). Occipital condyle syndrome mimicking giant cell arteritis as the first manifestation of disseminated malignancy. Internal Medicine Journal, 48(9), 1163-1164. Scopus2 WoS1 |
| 2018 | Lowe, J., Briggs, A., Whittle, S., Hoon, E., & Stephenson, M. (2018). Effectiveness of probiotics in the management of inflammatory arthritis: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Report, 16(12), 2295-2303. Scopus6 Europe PMC3 |
| 2017 | Wilsdon, T. D., Whittle, S. L., Thynne, T. R. J., & Mangoni, A. A. (2017). Methotrexate for psoriatic arthritis. Cochrane Database of Systematic Reviews, 2017(7). Scopus41 |
| 2017 | Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Research and Therapy, 19(1), 253-1-253-8. Scopus40 WoS39 Europe PMC31 |
| 2017 | Truong, S. L., Saad, N. F., Robinson, P. C., Cowderoy, G., Lim, I., Schachna, L., . . . Brown, M. A. (2017). Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand. Journal of Medical Imaging and Radiation Oncology, 61(1), 58-69. Scopus10 WoS10 Europe PMC6 |
| 2017 | Haghighi, P. D., Kang, Y. B., Buchbinder, R., Burstein, F., & Whittle, S. (2017). Investigating subjective experience and the influence of weather among individuals with fibromyalgia: A content analysis of Twitter. Jmir Public Health and Surveillance, 3(1), e4. Scopus18 Europe PMC11 |
| 2017 | Goldacre, B., Whittle, S., Ernst, E., & Mendel, J. (2017). Authors' reply to Beales. BMJ Online, 356, 1 page. |
| 2016 | Pisaniello, H. L., & Whittle, S. (2016). Fibromyalgia: Finding the silver lining around a common chronic pain disorder. Medicine Today, 17(12), 54-56. |
| 2016 | Milman, N., Whittle, S., Hill, C., El Sayad, J., & Wells, G. (2016). Methotrexate for polymyalgia rheumatica. Cochrane Database of Systematic Reviews, 2016(5), 9 pages. |
| 2016 | Milman, N., Hill, C., Whittle, S., El Sayad, J., & Wells, G. (2016). Methotrexate for giant cell arteritis. Cochrane Database of Systematic Reviews, 2016(5), 9 pages. Scopus1 |
| 2016 | Tieu, J., Lester, S., Whittle, S., Peh, C. A., Goldblatt, F., Proudman, S., . . . Hill, C. (2016). RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF USE IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 46, 35. |
| 2016 | Bird, P., Shnier, R., Taylor, A., White, C., Whittle, S., Basic, N., . . . Tesla, P. (2016). EFFECT OF CALIBRATION AND TRAINING ON MAGNETIC RESONANCE IMAGING SACROILIITIS SCORING AND SI JOINT RADIOGRAPHIC SCORING AGREEMENT. INTERNAL MEDICINE JOURNAL, 46, 38. |
| 2016 | Mendel, J., Goldacre, B., Ernst, E., & Whittle, S. (2016). Problems with ethical approval and how to fix them: Lessons from three trials in rheumatoid arthritis. BMJ (Online), 354, 1-4. Scopus7 WoS6 Europe PMC3 |
| 2015 | Ting, K., Graf, S. W., & Whittle, S. L. (2015). Update on the diagnosis and management of gout. MEDICAL JOURNAL OF AUSTRALIA, 203(2), 86-+. WoS3 |
| 2015 | Whittle, S., & Buchbinder, R. (2015). Rotator Cuff Disease. ANNALS OF INTERNAL MEDICINE, 162(1), ITC1-ITC16. WoS69 |
| 2015 | Ting, K., Hill, C., & Whittle, S. (2015). Quality of reporting of interventional animal studies in rheumatology: a systematic review using the ARRIVE guidelines. International Journal of Rheumatic Diseases, 18(5), 488-494. Scopus35 WoS37 Europe PMC29 |
| 2015 | Ting, K., Graf, S. W., & Whittle, S. L. (2015). Update on the diagnosis and management of gout. Medical Journal of Australia, 203(2), 86-88. Scopus5 WoS1 Europe PMC3 |
| 2015 | Whittle, S., & Buchbinder, R. (2015). Rotator cuff disease. Annals of Internal Medicine, 162(1), ITC1-ITC15. Scopus85 WoS1 Europe PMC70 |
| 2015 | Graf, S., Whittle, S., Wechalekar, M., Moi, J., Barrett, C., Hill, C., . . . Zochling, J. (2015). Australian and New Zealand recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion in the 3e Initiative. International Journal of Rheumatic Diseases, 18(3), 341-351. Scopus54 WoS37 Europe PMC34 |
| 2014 | Graf, S. W., & Whittle, S. L. (2014). Isotretinoin-induced skeletal hyperostosis. SpringerPlus, 3(1), 698-1-698-4. Scopus7 WoS7 Europe PMC6 |
| 2014 | Moghaddami, M., James, M., Whittle, S., & Cleland, L. (2014). Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitro. Clinical & Translational Immunology, 3(8), e23-1-e23-7. Scopus1 WoS1 |
| 2014 | Richards, B. L., Whittle, S., Buchbinder, R., Barrett, C., Lynch, N., Major, G., . . . Zochling, J. (2014). Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis. International Journal of Rheumatic Diseases, 17(7), 738-748. Scopus3 WoS2 Europe PMC2 |
| 2014 | Robinson, P., Bird, P., Lim, I., Saad, N., Schachna, L., Taylor, A., . . . Brown, M. (2014). Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). International Journal of Rheumatic Diseases, 17(5), 548-556. Scopus12 WoS10 Europe PMC9 |
| 2014 | Bourne, A. M., Whittle, S. L., Richards, B. L., Maher, C. G., & Buchbinder, R. (2014). The scope, funding and publication of musculoskeletal clinical trials performed in Australia. Medical Journal of Australia, 200(2), 88-91. Scopus22 WoS21 Europe PMC19 |
| 2013 | Graf, S., Buchbinder, R., Zochling, J., & Whittle, S. (2013). The accuracy of methods for urate crystal detection in synovial fluid and the effect of sample handling: A systematic review. Clinical Rheumatology, 32(2), 225-232. Scopus32 WoS24 Europe PMC18 |
| 2013 | Whittle, S., Richards, B., & Buchbinder, R. (2013). Opioid analgesics for rheumatoid arthritis pain. JAMA: Journal of the American Medical Association, 309(5), 485-486. Scopus27 WoS25 Europe PMC22 |
| 2012 | Wechalekar, M., Lester, S., Proudman, S., Cleland, L., Whittle, S., Rischmueller, M., & Hill, C. (2012). Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis and Rheumatism, 64(5), 1316-1322. Scopus54 WoS52 Europe PMC41 |
| 2012 | Whittle, S., Colebatch, A., Buchbinder, R., Edwards, C., Adams, K., Englbrecht, M., . . . van der Heijde, D. (2012). Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e initiative. Rheumatology, 51(8), 1416-1425. Scopus84 WoS58 Europe PMC43 |
| 2012 | Whittle, S. L., Richards, B. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of opioids in inflammatory arthritis: a cochrane systematic review. The Journal of Rheumatology, 39(Suppl. 90), 40-46. Scopus18 WoS19 Europe PMC16 |
| 2012 | Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review. The Journal of Rheumatology, Suppl. 90(SUPPL. 90), 34-39. Scopus16 WoS11 Europe PMC6 |
| 2012 | Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. Journal of Rheumatology, 39(90), 21-27. Scopus23 WoS15 Europe PMC11 |
| 2012 | Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). Efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review. Journal of Rheumatology, 39(Suppl. 90), 28-33. Scopus10 WoS7 Europe PMC4 |
| 2012 | Richards, B., Whittle, S., & Buchbinder, R. (2012). Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews, 1(1), 1-51. Scopus84 WoS69 Europe PMC48 |
| 2012 | Richards, B., Whittle, S., & Buchbinder, R. (2012). Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2012(1), CD008922-1-CD008922-38. Scopus74 WoS33 Europe PMC27 |
| 2012 | Leah, E. (2012). Rheumatoid arthritis: Putting feet forward in disease assessment.. Nature reviews. Rheumatology, 8(2), 64. |
| 2011 | Richards, B. L., Whittle, S. L., & Buchbinder, R. (2011). Antidepressants for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews (Online), 11(11), 1-67. Scopus61 WoS40 Europe PMC41 |
| 2011 | Whittle, S. L., Richards, B. L., Husni, E., & Buchbinder, R. (2011). Opioid therapy for treating rheumatoid arthritis pain. Cochrane database of systematic reviews (Online), (11), 1-60. Scopus105 WoS84 Europe PMC54 |
| 2010 | Katikireddi, V., Whittle, S., & Hill, C. (2010). Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis. International Journal of Rheumatic Diseases, 13(1), 12-26. Scopus22 WoS19 Europe PMC15 |
| 2010 | Wechalekar, M. D., Rischmueller, M., Whittle, S., Burnet, S., & Hill, C. L. (2010). Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. Journal of Clinical Rheumatology, 16(2), 79-80. Scopus20 WoS16 Europe PMC14 |
| 2009 | Hill, C. L., Cole, A., Lester, S., & Whittle, S. L. (2009). Steroid sparing drug treatments for giant cell arteritis. Cochrane Database of Systematic Reviews, (1). Scopus2 |
| 2009 | Whittle, S. L., Cole, A., Lester, S., & Hill, C. L. (2009). Steroid sparing drug treatments for polymyalgia rheumatica. Cochrane Database of Systematic Reviews, (1). |
| 2008 | Mangat, P., Whittle, S., Cleland, L., & Limaye, S. (2008). Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy. Clinical Rheumatology, 27(12), 1593-1595. Scopus3 WoS3 Europe PMC2 |
| 2004 | Whittle, S. L., & Hughes, R. A. (2004). Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review. Rheumatology, 43(3), 267-271. Scopus237 WoS192 Europe PMC148 |
| 2004 | Bamji, A., Whittle, S., & Hughes, R. A. (2004). Methotrexate and folic: What is the optimal combination? (multiple letters) [7]. Rheumatology, 43(8), 1060-1061. Scopus1 Europe PMC1 |
| 2004 | Whittle, S., & Hughes, R. A. (2004). Methotrexate and folic acid: what is the optimal combination? Reply. RHEUMATOLOGY, 43(8), 1061. |
| 2002 | Whittle, S., James, M., & Cleland, L. G. (2002). Focus on meloxicam. Medicine Today, 3(9), 73-76. |
| 1996 | Edwards, D. J., Whittle, S. L., Nissen, M. J., Cohen, B., Oakeshott, R. D., & Keene, G. C. R. (1996). Radiographic changes in the knee after meniscal transplantation - An experimental study in a sheep model. AMERICAN JOURNAL OF SPORTS MEDICINE, 24(2), 222-226. WoS28 Europe PMC21 |
| - | Mittinty, M. M., Mittinty, M., Buchbinder, R., Lassere, M., Chand, V., Whittle, S., . . . Hill, C. (n.d.). Dyadic Coping with Rheumatoid Arthritis: A Couple Perspective from the Australian Rheumatology Association Database Registry. SSRN Electronic Journal. |
| Year | Citation |
|---|---|
| 2025 | Hazlewood, G., Jung, M., Kaminska, E., Bansback, N., Buchbinder, R., Whittle, S., . . . Barber, C. (2025). One-Year Outcomes After Decision Aid-Led Tapering of Advanced Therapy in Rheumatoid Arthritis. In JOURNAL OF RHEUMATOLOGY Vol. 52 (pp. 2 pages). J RHEUMATOL PUBL CO. |
| 2024 | Hill, C., Kwon, M., Chin, A., Lester, S., & Whittle, S. (2024). DMARD MONITORING IN RHEUMATOID ARTHRITIS: A SCOPING REVIEW OF INTERNATIONAL/NATIONAL GUIDELINES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). AUSTRIA, Vienna: ELSEVIER. DOI |
| 2024 | Terrett, A., Chin, A., Kwon, M., Whittle, S., & Hill, C. (2024). Recommendations for the Perioperative Use of DMARDs in Rheumatic Diseases: A Scoping Review. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 2123-2124). WILEY. |
| 2023 | Crouch, B., Kwiatek, R., True, B., Whittle, S., Wall, A., & Sherwood, V. (2023). DIFFUSION TENSOR IMAGING IN FIBROMYALGIA SYNDROME-A PILOT STUDY. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 32-33). WILEY. |
| 2023 | Kwiatek, R., & Whittle, S. (2023). MEMANTINE-A USEFUL BUT FORGOTTEN PAIN MODULATOR IN FIBROMYALGIA MANAGEMENT? A CLINICAL AUDIT. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 33). WILEY. |
| 2023 | Schwetlik, S., Wigg, A., Tieu, J., Lyne, S., Whittle, S., Proudman, S., & Hill, C. (2023). THE VALUE OF AN ADVANCED PRACTICE PHYSIOTHERAPIST-LED NEW PATIENT RHEUMATOLOGY SERVICE: A CLINICAL AUDIT OF THE MUSCULOSKELETAL ASSESSMENT CLINIC AT THE QUEEN ELIZABETH HOSPITAL. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 17-18). WILEY. |
| 2023 | Sukkar, M., Keen, H., March, L., Proudman, S., Bradbury, L., Hardy, L., . . . Hill, C. (2023). DEVELOPING QUALITY STANDARDS FOR THE DIAGNOSIS AND MANAGEMENT OF RHEUMATOID ARTHRITIS IN AUSTRALIA. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 52). WILEY. |
| 2023 | Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. (2023). POORER PAIN-RELATED HEALTH STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS CORRELATES WITH AN INCREASE IN HOSPITALISATIONS AND MORTALITY: A PROSPECTIVE COHORT ANALYSIS USING THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 22). WILEY. |
| 2023 | Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. (2023). TRAJECTORIES OF SELF-REPORTED PAIN-RELATED HEALTH OUTCOMES AND THE ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS AND MEDICATION USE IN RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT ANALYSIS USING THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 21-22). WILEY. |
| 2023 | Dartnell, J., Brown, S., Barrett, C., Hardy, L., Buchbinder, R., Whittle, S., . . . Hill, C. (2023). COLLECTIVE IMPACT APPROACH FOR MORE EFFECTIVE KNOWLEDGE TRANSLATION. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 53). WILEY. |
| 2023 | Lovato, N., Reynolds, A., Whittle, S., Watson, N., Dyer, K., Gill, T., . . . Hill, C. (2023). DEFINING CLINICAL SLEEP DISORDERS IN FIBROMYALGIA: ROLE FOR UNIVERSAL SCREENING?. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 41). WILEY. |
| 2022 | Khoo, T., Lester, S., Hill, C., Whittle, S., Black, R., Tieu, J., & Rischmueller, M. (2022). CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE IN A RHEUMATOLOGY CLINIC POPULATION. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. |
| 2022 | Russell, O., Khoo, T., Hill, C., Whittle, S., Tieu, J., Lyne, S., & Burnet, S. (2022). AN EXPERIENCE OF THE FIRST PUBLIC RURAL RHEUMATOLOGY CLINIC IN SOUTH AUSTRALIA (SA). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. |
| 2022 | Ye, M. J., Sinnathurai, P., Hill, C., Barrett, C., Hardy, L., Buchbinder, R., . . . Quyen, D. (2022). ENGAGING CLINICIANS AND CONSUMERS IN THE DESIGN AND IMPLEMENTATION OF A NATIONAL EDUCATION PROGRAM FOR INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 31). WILEY. |
| 2021 | Khoo, T., Hill, C., Hoon, E., & Whittle, S. (2021). MEDICATION USE, COMORBIDITIES AND DISEASE ACTIVITY OF PATIENTS WITH FIBROMYALGIA IN A HOSPITAL OUTPATIENT CLINIC. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 48). WILEY. |
| 2021 | Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Marine, F., . . . Hill, C. (2021). VACCINATION RATES, PERCEPTIONS AND INFORMATION SOURCES UTILISED BY AUSTRALIAN PATIENTS WITH INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 15). WILEY. |
| 2021 | Sheppard, J., Dartnell, J., Granger, R., Sinnathurai, P., Buchbinder, R., Hill, C., . . . Hayward, K. (2021). INITIATING A NATIONAL CONSORTIUM APPROACH TO SUPPORT OPTIMAL USE OF bDMARDs. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 22-23). WILEY. |
| 2021 | Kwiatek, R., Crouch, B., True, B., Whittle, S., Walls, A., & Sherwood, V. (2021). NEUROINFLAMMATION IN PRECUNEUS AND ISOLATED ELEVATED CHOLINE IN MEDIAL PREFRONTAL CORTEX CONFIRMED IN FIBROMYALGIA SYNDROME. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 43-44). WILEY. |
| 2021 | Johnson, J., Lynch, L., Gordon, M., Whittle, S., & Hill, C. (2021). EXPLORING OPIOID USE IN THE CONTEXT OF RHEUMATOLOGY DISEASE IN AN OUTPATIENT SETTING. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 24-25). WILEY. |
| 2021 | Danicic, J., Jung, M., Stamp, L., Dalbeth, N., & Whittle, S. (2021). STEM CELL THERAPY FOR MUSCULOSKELETAL DISEASES: A RAPID REVIEW. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 35). WILEY. |
| 2021 | Lian, A., Keen, H., Whittle, S., & Sharma, C. (2021). A COMPARISON BETWEEN RHEUMATOID ARTHRITIS PAIN DESCRIPTORS IN UNPROMPTED FREE TEXT FROM THE INTERNET AND THE MacGill PAIN QUESTIONNAIRE. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 48). WILEY. |
| 2021 | Tiller, G., Renton, W., Munro, J., Whittle, S., Avery, J., Johnston, R., & Buchbinder, R. (2021). APRG MEMBER SURVEY TO IDENTIFY PRIORITY QUESTIONS FOR A LIVING GUIDELINE FOR THE PHARMACOLOGICAL MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 36). WILEY. |
| 2020 | Jimenez, D. F., Duron, G., Duarte-Garcia, A., Sufka, P., Whittle, S., Robinson, P., . . . Putman, M. (2020). A Systematic Review to Quantify the Extent of Pharmaceutical Company Involvement in Rheumatology Consensus-Based Recommendations. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 4 pages). ELECTR NETWORK: WILEY. |
| 2020 | Kwiatek, R., Crouch, B., True, B., Whittle, S., Walls, A., & Sherwood, V. (2020). NEUROINFLAMMATION IN FIBROMYALGIA ASSESSED BY PROTON MAGNETIC RESONANCE SPECTROSCOPY - A PILOT STUDY. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 48-49). WILEY. |
| 2020 | Davis, C., Ruediger, C., Dyer, K., Lester, S., Graf, S., Kroon, F. P. B., . . . Hill, C. (2020). COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH). In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 793-794). ELECTR NETWORK: ELSEVIER. DOI WoS2 |
| 2020 | Dartnell, J., Elliott, J., Buchbinder, R., Hill, C., Barrett, C., Marine, F., . . . de Wever, J. (2020). DEVELOPING A COLLABORATIVE NATIONAL PROGRAM TO OPTIMISE USE OF BDMARDS. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 40-41). WILEY. |
| 2020 | Whittle, S., & Buchbinder, R. (2020). DURABILITY OF RHEUMATOLOGY GUIDELINE RECOMMENDATIONS: AN ANALYSIS OF UPDATED EULAR GUIDELINES 2005-2019. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 41). WILEY. |
| 2020 | Whittle, S., Thomas, M., Kamso, M. M., Pardo, J. P., Buchbinder, R., & Hazlewood, G. (2020). A LIVING NETWORK META-ANALYSIS OF TREATMENTS FOR RHEUMATOID ARTHRITIS: NOVELTY AT THE FRONTIER OF LIVING EVIDENCE. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 39). WILEY. |
| 2019 | Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., Sa'adon, R., & Keen, H. (2019). Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 2 pages). GA, Atlanta: WILEY. |
| 2018 | Calderon, L., Whittle, S., Hill, C., Sayad, J., Wells, G., & Milman, N. (2018). Methotrexate for Polymyalgia Rheumatica. In JOURNAL OF RHEUMATOLOGY Vol. 45 (pp. 1025-1026). Vancouver, CANADA: J RHEUMATOL PUBL CO. |
| 2018 | Leonardo, N., Lester, S., Graham, M., Whittle, S., Rowett, D., Buchbinder, R., & Hill, C. (2018). Attitudes and Beliefs Regarding Methotrexate in Patients with Rheumatoid Arthritis: Results from Australian Rheumatology Association Database. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY. WoS1 |
| 2013 | Merriman, T., Phipps-Green, A., Black, M., Cadzow, M., Merriman, M., Topless, R., . . . Batt, C. (2013). SUGAR-SWEETENED BEVERAGE CONSUMPTION: A RISK FACTOR FOR PREVALENT GOUT THAT INTERACTS WITH SLC2A9 GENOTYPE IN A NON-ADDITIVE FASHION. In INTERNAL MEDICINE JOURNAL Vol. 43 (pp. 2). WILEY-BLACKWELL. |
| 2003 | Whittle, S., Lester, S. E., Downie-Doyle, S., Pile, K. D., & Rischmueller, M. (2003). Estrogen receptor alpha IVS1-401 (T/C) polymorphism in primary Sjogren's syndrome.. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S567). ORLANDO, FLORIDA: WILEY-LISS. |
| Year | Citation |
|---|---|
| 2021 | Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2021). ATTITUDES OF AUSTRALIANS WITH INFLAMMATORY ARTHRITIS TO BIOLOGIC THERAPY AND BIOSIMILARS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2020). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Davis, C., Ruediger, C., Dyer, K., Lester, S., Graf, S., Kroon, F., . . . Hill, C. (2020). COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. WoS1 |
| 2020 | Whittle, S., Hill, C., & Buchbinder, R. (2020). ARA MEMBER SURVEY TO IDENTIFY PRIORITY QUESTIONS FOR A LIVING GUIDELINE FOR THE PHARMACOLOGICAL MANAGEMENT OF RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. WoS2 |
| 2020 | Khoo, T., Hill, C., & Whittle, S. (2020). MEDICATION USE AND COMORBIDITIES OF PATIENTS WITH FIBROMYALGIA IN A HOSPITAL OUTPATIENT CLINIC. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S., Hill, C., Rowett, D., . . . Buchbinder, R. (2020). CLINICIAN PERSPECTIVES FACTORS INFLUENCING PRESCRIBING AND USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN INFLAMMATORY RHEUMATIC DISORDERS FROM THE PERSPECTIVES OF CLINICIANS: A QUALITATIVE EVIDENCE SYNTHESIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Lee, C., Thomas, M., Whittle, S., Buchbinder, R., Kamso, M., Pardo, J., & Hazlewood, G. (2020). Development and Pilot of Novel Process Using Machine Learning and Crowd-Sourcing to Conduct a Living Systematic Review of Rheumatoid Arthritis Drug Therapy. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Victoria, CANADA: J RHEUMATOL PUBL CO. |
| 2019 | Calderon, L., Milman, N., Hill, C., Whittle, S., Sayad, J., Wells, G., & Pardo, J. (2019). Methotrexate for Giant Cell Arteritis. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Montreal, CANADA: J RHEUMATOL PUBL CO. |
| 2018 | Leonardo, N., Lester, S., Graham, M., Whittle, S., Rowett, D., Buchbinder, R., & Hill, C. (2018). ATTITUDES OF RHEUMATOID ARTHRITIS PATIENTS TO METHOTREXATE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2018 | Chan, F., Lester, S., Whittle, S., & Hill, C. (2018). THE UTILITY OF ESR, CRP AND PLATELETS IN THE DIAGNOSIS OF GCA: A SOUTH AUSTRALIAN STATEWIDE ANALYSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2017 | Whittle, S., Menz, F., Lester, S., Proudman, S., & Hill, C. (2017). THE DAS28-P INDEX AS A PREDICTOR OF POOR SUBJECTIVE RESPONSE TO DMARD THERAPY IN EARLY RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. WoS1 |
| 2017 | Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). FACTORS ASSOCIATED WITH ORAL GLUCOCORTICOID USE IN PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2017 | Pisaniello, H., Lester, S., Gonzalez-Chica, D., Longo, M., Sharplin, G., Dal Grande, E., . . . Hill, C. (2017). PREVALENCE AND PREDICTORS OF GOUT AND ALLOPURINOL USE, AND THEIR ASSOCIATION WITH RISK PERCEPTION: RESULTS FROM A SOUTH AUSTRALIAN POPULATION-BASED STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. WoS1 |
| 2015 | Ting, K., Whittle, S., & Hill, C. (2015). QUALITY OF REPORTING OF INTERVENTIONAL ANIMAL STUDIES IN RHEUMATOLOGY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2015 | Haghighi, P. D., Kang, Y. -B., Tuan, H., Buchbinder, R., Burstein, F., & Whittle, S. (2015). Investigation of Environmental Associations of Fibromyalgia Pain Using Twitter Content Analysis. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY. |
| 2013 | Bourne, A., Whittle, S., Richards, B., Maher, C., & Buchbinder, R. (2013). MUSCULOSKELETAL CLINICAL TRIALS IN AUSTRALIA: WHAT TRIALS ARE BEING PERFORMED, WHO IS FUNDING THEM AND WHERE ARE THEY BEING PUBLISHED?. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2011 | Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF MUSCLE RELAXANTS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC LITERATURE REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2011 | Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF NEUROMODULATORS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2011 | Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF ANTI-DEPRESSANTS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2011 | Whittle, S., Richards, B., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF OPIOIDS IN RHEUMATOID ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2016 - 2018 | Treasurer | Australian Rheumatology Association | Australian Rheumatology Association | Australia |
Connect With Me
External Profiles
